Theliatinib (Xiliertinib) tartrate is a potent and highly selective EGFR inhibitor with ATP-competitive and orally active properties, showing a K_i of 0.05 nM and an IC_50 of 3 nM for EGFR, and an IC_50 of 22 nM for the EGFR T790M/L858R mutant, with over 50-fold selectivity for EGFR compared to other kinases.
Molecular Weight:
592.6
CAS Number:
[2413487-72-4]
Formula:
C29H32N6O8
Target:
EGFR|||Others
T72431
* VAT and and shipping costs not included. Errors and price changes excepted